
éºäŒåæ€æ»ã¯åŸããçããå€ããïŒMicrosoftãTalosããèªã
éºäŒåæ€æ»ã§åå ãåãããªãã£ããããã®çµæã¯ãã£ãšå€ãããªãã®ã§ãããããå®ã¯ãæ€æ»æç¹ã§ã¯äžæã§ããæ°ããéºäŒåãšç æ°ã®é¢ä¿ãçºèŠãããããšã§ãä¿åæžã¿ããŒã¿ããåŸã«æããããèŠã€ããå ŽåããããŸãã
Microsoft Researchã¯2026幎6æ24æ¥ãåžå°çŸæ£ã®ã²ãã ããŒã¿ã宿çã«åè§£æãããªãŒãã³ãœãŒã¹åºç€ãTalosãã玹ä»ããŸããã
ãã®èšäºã§ã¯ãå ¬åŒããã°ãšNature Medicineæ²èŒç ç©¶ã§ç¢ºèªã§ããäºå®ãšãçè ã®èå¯ãåããŠèŠãŠãããŸããåå¥ã®èšºæãæ²»çãæ¡å ããèšäºã§ã¯ãããŸããã
1ïŒãªãäžåºŠã®æ€æ»ã§çµãããªãã®ã
ãäºå®ã
ã²ãã æ€æ»ã鲿©ããŠããæåã®æ€æ»ã§èšºæã«è³ããªãæ£è
ã¯åæ°ãè¶
ãããšMicrosoft Researchã¯èª¬æããŠããŸããçç±ã®äžã€ã¯ã人éã®éºäŒåãšç
æ°ã®é¢ä¿ã«ã€ããŠãç§åŠã®çè§£ããŸã æŽæ°ããç¶ããŠããããšã§ãã
ã²ãã ããŒã¿ã¯ä¿åããåŸããåã³èª¿ã¹ãããŸããæ€æ»æã«ã¯æå³ãåãããªãã£ãå€ç°ã§ããæ°ããç ç©¶ææãå顿 å ±ãå ¬éãããåŸãªãã蚺æã«ã€ãªããåè£ã«ãªãå¯èœæ§ããããŸãã
2ïŒåè§£æã®å£ã¯äººã®æé
ãäºå®ã
ä¿åããŒã¿ãèŠçŽããåè§£æãã¯æå¹ã§ãããåŸæ¥ã¯å€ãã®äœæ¥ãæåã§ãããèšåºå»ãæ€æ»å®€ã®å°éå®¶ãäžè¶³ããè²»çšè² æ
ã®ä»çµã¿ãäžå®ã§ãªãããã倿°ã®ã²ãã ãåã³èª¿ã¹ãããªããŸãŸèç©ããŠãããšãããŠããŸãã
ãçè
ã®èå¯ã
èšç®ãã®ãã®ãããåè£ãäžã€ãã€ç¢ºèªããå°éå®¶ã®æéãããã«ããã¯ã§ããèªååã§ã¯ãåè£ã倧éã«äžŠã¹ãããã確èªãã¹ããã®ãæ
éã«çµãããšãéèŠã«ãªããŸãã
3ïŒTalosã¯äœãããã®ã
ãäºå®ã
Talosã¯ãä¿åæžã¿ã®éºäŒåå€ç°ããŒã¿ãããã®æç¹ã§ææ°ã®å
¬éç¥èãšç
§ããåãããŸããéºäŒåãšç
æ°ã®é¢ä¿ã«ã¯PanelApp Australiaãå€ç°ã®ç
åæ§æ
å ±ã«ã¯ClinVarãå©çšããŸãã
ããã«ãéºäŒåœ¢åŒãå®¶ææ§æãæ°ãã«çããå€ç°ãã©ãããå©çšã§ããå Žåã¯æ£è ã®çç¶æ å ±ã䜿ããèšåºçã«éèŠã§ããå¯èœæ§ãé«ãåè£ãçµããŸãã
4ïŒãããããåºãããããå°ãªãåºãã
ãäºå®ã
Talosã¯é·ãåè£äžèЧã§ã¯ãªããä¿¡é ŒåºŠã®é«ãå°æ°ã®åè£ãè¿ããããä¿å®çã«èšèšãããŠããŸãããŸããç¹°ãè¿ãå®è¡ãããšãååããæ ¹æ ãå€ãã£ãåè£ã ãã衚瀺ããŸãã
1,089人ã®åžå°çŸæ£æ£è ããŒã¿ã䜿ã£ãæ€èšŒã§ã¯ã察象ç¯å²å ã®æ¢ç¥èšºæã®90ïŒ ãæŸããªãããå°éå®¶ã確èªããåè£ã¯1çäŸãããå¹³å1.3ä»¶ã§ããã
5ïŒçŽ4,700人ãžã®é©çšã§äœãèŠã€ãã£ãã
ãäºå®ã
ç ç©¶ããŒã ã¯ãæ€æ»æžã¿ã§ãæªèšºæã ã£ã4,735人ã®ã³ããŒãã«Talosãé©çšããŸããããã®çµæã238人ã§241ä»¶ã®æ°ãã蚺æãåŸããã远å ã®èšºæçã¯5.1ïŒ
ã§ããã
æ°ãã蚺æã®ãã¡ã32ïŒ ã¯æ°ãã«å€æããéºäŒåãšç æ°ã®é¢ä¿ã22ïŒ ã¯å€ç°ã¬ãã«ã®æ°ãã蚌æ ã45ïŒ ã¯åææ¹æ³ãçµã蟌ã¿ã®æ¹åã«ãããã®ã§ãããåå åè£ã¯èªå®æ€æ»æ©é¢ã§ç åæ§ãŸãã¯ç åæ§ã®å¯èœæ§ãé«ããšç¢ºèªãããŠããŸãã
6ïŒæ¯æèŠçŽããšè² æ ã¯å¢ããããªãã
ãäºå®ã
Talosã¯29åã®ææ¬¡ãµã€ã¯ã«ã§å埩éçšãããŸãããæåã®è§£æåŸã¯ãæ°ãã«æ ¹æ ãå€ãã£ããã®ã ããè¿ããããææ¬¡åè§£æã§å°éå®¶ã確èªããæ°èŠåè£ã¯å¹³å200çäŸã«ã€ã1ä»¶ã§ããã
æ°ããç§åŠçæ ¹æ ãå ¬éãããŠãã蚺æã«è³ããŸã§ã®å¹³åã¯32æ¥ã§ãããé »ç¹ãªèŠçŽããšãå°éå®¶ã®ç¢ºèªè² æ ãäž¡ç«ã§ããå¯èœæ§ã瀺ããçµæã§ãã
7ïŒèªååã蚺æã決ããããã§ã¯ãªã
ãäºå®ã
Talosã®åœ¹å²ã¯ãææ°ç¥èãšã®ç
§åãšåè£ã®åªå
é äœä»ãã§ããå
¬åŒçºè¡šã®æµãã§ã¯ãåè£ãšæ ¹æ ãèšåºããŒã ãžæç€ºãããå°éå®¶ã確èªããŸãã
ãŸãã90ïŒ ãšããå€ã¯ã察象ç¯å²å ã®æ¢ç¥èšºæããæŸã£ãæ€èšŒçµæã§ãããã¹ãŠã®åžå°çŸæ£ã90ïŒ èšºæã§ãããšããæå³ã§ã¯ãããŸãããä¿å®çãªèšèšã®ãããTalosãæŸããã人ã®è§£æã§èŠã€ãã£ãäŸãå ±åãããŠããŸãã
8ïŒå»çAIã§å€§åãªåœ¹å²åæ
ãçè
ã®èå¯ã
Talosã®äŸ¡å€ã¯ãå°éå®¶ã眮ãæããããšã§ã¯ãªããæŽæ°ãããèšå€§ãªç¥èãç£èŠãã確èªãã¹ãå°æ°ã®åè£ãæºåããããšã«ãããŸãã
AIãèªååã«ã¯ãããŒã¿ã®ç §åã倿Žç¹ã®æ€åºãåè£ã®çµã蟌ã¿ãä»»ããã人ã¯ãæ£è ã®çç¶ãå®¶ææŽãæ€æ»ã®éçãå«ççãªåœ±é¿ãèžãŸããŠå€æãããå»çã®ããã«çµæã人çãžçŽçµããåéã§ã¯ããã®å¢çãæç¢ºã«ä¿ã€ããšãæ¬ ãããŸããã
âïž èè ã®ææ³
äžåºŠã®æ€æ»ã§çããåºãªããŠããç§åŠã®é²æ©ã«ãã£ãŠåŸããæå³ãèŠã€ãããšããç¹ã«åžæãæããŸãããåæã«ãä¿åããŒã¿ãäœåºŠãèŠçŽãã«ã¯ãæè¡ã ãã§ãªãåæããã©ã€ãã·ãŒãéçšè²¬ä»»ãå¿ èŠã§ãã
AIã«ã¯ææ°æ å ±ã®åéãåè£æŽçãªã©ã®æºåäœæ¥ãä»»ããäººã¯æ ¹æ ã確ãããæ¬äººãå®¶æãžã®åœ±é¿ãèããŠéèŠãªå€æãããããã®åæ ããããããããèªååãå®å šã«åœ¹ç«ãŠãããã®ã ãšæããŸãã
ð ãŸãšã
ã»ã²ãã ããŒã¿ã¯ç§åŠç¥èã®æŽæ°åŸã«åè§£æã§ãã
ã»Talosã¯å
¬éç¥èãšç
§åãã確èªåè£ãå°æ°ã«çµã
ã»1,089äººã®æ€èšŒã§å¯Ÿè±¡ç¯å²å
ã®æ¢ç¥èšºæã®90ïŒ
ãæŸã£ã
ã»å°éå®¶ãèŠãåè£ã¯1çäŸãããå¹³å1.3ä»¶ã ã£ã
ã»4,735人ãžã®é©çšã§241ä»¶ã5.1ïŒ
ã®è¿œå 蚺æãåŸããã
ã»ææ¬¡åè§£æã§ã¯æ°èŠåè£ãå¹³å200çäŸã«ã€ã1ä»¶ã ã£ã
ã»èªååã¯æºåãæ¯æŽãã蚺æå€æã¯å°éå®¶ãæ
ã
åºå ž
Microsoft Research, âTalos: Scaling rare disease diagnosis with automated, iterative genomic reanalysisâ (2026幎6æ24æ¥)
https://www.microsoft.com/en-us/research/blog/talos-scaling-rare-disease-diagnosis-with-automated-iterative-genomic-reanalysis/
Microsoft Research / Nature Medicine, âAutomated reanalysis of genomic data for rare disease diagnostics at scaleâ (2026幎6æ)
https://www.microsoft.com/en-us/research/publication/automated-reanalysis-of-genomic-data-for-rare-disease-diagnostics-at-scale/
#AI #人工ç¥èœ #åžå°çŸæ£ #ã²ãã è§£æ #éºäŒåæ€æ» #Talos #å»çAI #MicrosoftResearch